APA (7th ed.) Citation

Lin, J., Zhuang, F., Chen, W., Lin, Z., Chen, Y., Chen, X., . . . Wang, F. (2025). Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-06672-3

Chicago Style (17th ed.) Citation

Lin, Jun-Peng, et al. "Neoadjuvant Chemoimmunotherapy Versus Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Esophageal Squamous Cell Carcinoma." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-06672-3.

MLA (9th ed.) Citation

Lin, Jun-Peng, et al. "Neoadjuvant Chemoimmunotherapy Versus Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Esophageal Squamous Cell Carcinoma." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-06672-3.